Serum concentration of pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with metastatic breast cancer.

  • Authors:
    • M Maemura
    • Y Iino
    • T Yokoe
    • H Takei
    • J Horiguchi
    • Y Koibuchi
    • F Ikeda
    • S Ohwada
    • I Takeyoshi
    • Y Morishita
  • View Affiliations

  • Published online on: November 1, 2000     https://doi.org/10.3892/or.7.6.1333
  • Pages: 1333-1341
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The serum concentration of pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) was examined in 83 patients with metastatic breast cancer. ICTP levels were significantly higher in patients with bone metastases than in those without bone metastasis. In patients with bone metastasis, significantly higher ICTP levels were observed in those with multiple lesions than in those with a solitary lesion and these levels reflected therapeutic response. Sequential monitoring of ICTP revealed that this elevation was correlated with disease progression. Combined with imaging studies, monitoring of ICTP appears to offer additional information for detection of bone metastasis and evaluation of therapeutic response to bone metastasis.

Related Articles

Journal Cover

Nov-Dec 2000
Volume 7 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Maemura M, Iino Y, Yokoe T, Takei H, Horiguchi J, Koibuchi Y, Ikeda F, Ohwada S, Takeyoshi I, Morishita Y, Morishita Y, et al: Serum concentration of pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with metastatic breast cancer.. Oncol Rep 7: 1333-1341, 2000
APA
Maemura, M., Iino, Y., Yokoe, T., Takei, H., Horiguchi, J., Koibuchi, Y. ... Morishita, Y. (2000). Serum concentration of pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with metastatic breast cancer.. Oncology Reports, 7, 1333-1341. https://doi.org/10.3892/or.7.6.1333
MLA
Maemura, M., Iino, Y., Yokoe, T., Takei, H., Horiguchi, J., Koibuchi, Y., Ikeda, F., Ohwada, S., Takeyoshi, I., Morishita, Y."Serum concentration of pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with metastatic breast cancer.". Oncology Reports 7.6 (2000): 1333-1341.
Chicago
Maemura, M., Iino, Y., Yokoe, T., Takei, H., Horiguchi, J., Koibuchi, Y., Ikeda, F., Ohwada, S., Takeyoshi, I., Morishita, Y."Serum concentration of pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with metastatic breast cancer.". Oncology Reports 7, no. 6 (2000): 1333-1341. https://doi.org/10.3892/or.7.6.1333